PRESENTATION ON:
AMINOGLYCOSIDE
INTEGRAL UNIVERSITY,LUCKNOW
Session: 2016-2017
Presented by: Under the guidence of:
Mohd Muztaba Dr .Anuradha Mishra
M.Pharm 1st year
Pharmacology
 These are a group of natural and semisynthetic antibiotics
having polybasic amino groups linked glycosidically to two or
more aminosugar (strephdine2-deoxy streptamine garosamine)
residue.
 Unlike penicilline which was a chance discovery
aminoglycosides are products of deliberate search for drugs
effective against gram-negative bacteria.
 All aminoglycosides are produced by soil actinomycetes
CLASSIFICATION
 Systemic aminoglycosides
Streptomycine, Amikacin
Gentamicin, Sisomicin
Kanamycin
 Topical aminoglycosides
Neomycin , Framycetin
 MECHANISM OF ACTION
 The aminoglycosides are bactericidal antibiotic
 Transport of the aminoglycosides through bacterial cell wall &
cytoplasmic membrane (diffusion-outer coat-Gm –ve via porin
channel)
 Irreversibly Binding to ribosomes (mostly 30s and 50s,30s
&50s interface) resulting in inhibition of protein synthesis.
Muztaba
MECHANISM OF RESISTANCE
 Production of a transferase enzyme or enzymes inactivates the
aminoglycoside by acetylation, or phosphorylation. This is
the principal type of resistance encountered clinically
 There is impaired entry of aminoglycoside into the cell. This
may be genotypic, resulting from mutation or deletion of a
proteins involved in transport and maintenance of the
electrochemical gradient; or phenotypic, eg, resulting from
growth conditions under which the oxygen-dependent
transport process described above is not functional
 The receptor protein on the 30S ribosomal subunit may be
deleted or altered as a result of a mutation.
 CONTRAINDICATIONS : hypersensitivity to aminoglycosides
or bisulfites
 DRUG INTERACTION :
• Inactivated by penicillins and cephalosporins when
coadministered to pateints with renal insufficiency.
• Increased incidence of ototoxicity with loop diuretics.
• Increased incidence of nephrotoxicity with other nephrotoxic
drugs.
 SIDE EFFECTS : nausea,vomiting,urticaria,muscles
weakness,rash etc.
 ADVERSE EFFECTS: vertigo,myocarditis,thrombocytopenia,
leukemia,hepatic necrosis,muscle paralysis, etc.
 TOXICITY : ototoxicity,nephrotoxicity
STREPTOMYCIN
• It is older antibiotics and obtained by Streptomyces griseus,
used in past but now used for treatment of TB
 M.O.A
• Inhibit initiation of translation by binding to 16s rRNA.
 MECHANISM OF RESISTANCE
• Mutations in (16sRNA) or (ribosomal protein) which produce
alterations in the streptomycin binding site
Cross resistance:
• Partial or unidirectional cross resistance occur.
Pharmacokinetics
• Neither absorbed nor destroyed in git.
• Absorption from injection site in muscle is rapid.
• Distributed extracellularly, volume of distribution 0.3 L/kg
• It is not metabolized. Excreted unchanged in urine
• Plasma half life is 2-4 hrs
Adverse effects
• Vestibular disturbances, auditory disturbances
• Nephrotoxicity
• Hypersensitivity are rare-rashes, eosinophilia, dermatitis
• Pain at injection site
CONTRAINDICATION: pregnancy causes foetal
ototoxicity
DOSE: Tb – 1g or 0.75 g i.m OD or thrice weekly for
30-60 days
Acute infection: 1g i.m OD or BD for 7-10 days
USES: TB, given with
pencillin/ampicillin/vancomycin for 4-6 weeks
• Plague: rapid cure within 7-12 days
• Tularemia: Streptomycin cures it in 7-10 days
GENTAMYCIN
 Gentamicin is an aminoglycoside isolated from
Micromonospora purpurea . It is effective against both gram-
positive and gram-negative organisms
Antimicrobial Activity
 Gentamicin sulfate inhibits in vitro many strains of
staphylococci and coliforms and other gram-negative bacteria.
RESISTANCE
 gentamicin in combination with vancomycin or a penicilline
produces a potent bactericidal effect, which in part is due to
enhanced uptake of drug that occurs with inhibition of cell wall
synthesis
 Resistance to gentamicin rapidly emerges in staphylococci
during monotherapy owing to selection of permeability
mutants. Ribosomal resistance is rare. Among gram-negative
bacteria, resistance is most commonly due to plasmid-encoded
aminoglycoside-modifying enzyme
 Gram-negative bacteria that are gentamicin-resistant usually
are susceptible to amikacin, which is much more resistant to
modifying enzyme activity.
AMIKACIN
 It is a semisynthetic aminoglycoside
 It is effective against several gram negative organism
including
Escherichia coli
Mycobacterium tuberculosis
 It is bactericidal effect Amikacin in highly effective against
pseudomonas
 RESISTANCE
 decreased uptake and/or accumulation of the drug in bacteria
the bacterial expression of enzymes which modify the
antibiotic and thereby inactivate it
ADVERSE EFFECT
• Vertigo
• Ataxia
• Ototoxicity
• Nephrotoxicity
USE
• Rt i
• Bone and joint infection
• Skin and soft tissue infection
INTRACTION
 Amphoterecin b may leads to increase nephrotoxicity and
reduce the clearance of amikacin when use in together
 Increse risk of ototoxicity with potent diuretics
NEOMYCIN & KANAMYCIN
 wide spectrum active against Gm-ve bacilli and some gm+ve
cocci and obtained from Streptomyces.fradiae
Antimicrobial Activity & Resistance
 Drugs of the neomycin group are active against gram-positive
and gram-negative bacteria and some mycobacteria.and
streptococci are generally resistant. Mechanisms of
antibacterial action and resistance are the same as with other
aminoglycosides.
 The widespread use of these drugs in bowel preparation for
elective surgery has resulted in the selection of resistant
organisms and some outbreaks of enterocolitis in hospitals.
Cross-resistance between kanamycin and neomycin is
complete.
 USES:Topically used in skin, eye and external ear
infections combined with bacitracin or polymyxin-B to
widen antibacterial spectrum and to prevent emergence of
resistant strains
Orally
 Preparation of bowel before surgery 1 gm TDS
ADVERSE EFFECT
 Applied topically neomycin has low sensitizing potential
However, rashes do occur.
 Oral neomycin has a damaging effect on intestinal villi-
prolonged treatment can induce malabsorption syndrome with
diarrhoea
 It can decrease the absorption of digoxin and many other
drugs, as well as bile acids.
FARAMYCETIN
 it is very similar to neomycin. It is too toxic for systemic
administration and is used topically on skin, eye, ear in the
same manner as neomycin.
THANK YOU

More Related Content

PPTX
Aminoglycosides antibiotics
PPT
30.aminoglycosides
PPTX
Aminoglycosides
PPTX
Aminoglycosides
PDF
Aminoglycoside and spectinomycin
PPTX
Aminoglycosides
PPTX
Aminoglycosides
PPTX
Aminoglycosides
Aminoglycosides antibiotics
30.aminoglycosides
Aminoglycosides
Aminoglycosides
Aminoglycoside and spectinomycin
Aminoglycosides
Aminoglycosides
Aminoglycosides

What's hot (20)

PPTX
Aminoglycosides antibiotics
PPT
30.aminoglycosides
PPT
Aminoglycoside ppt
PPTX
5 aminoglycosides,macrolides, anti tb dental
PPT
45 aminoglycosides
PPT
Aminoglycosides
PPTX
Aminoglycoside
PPTX
Class aminoglycosides 2
PPTX
Introduction to aminoglycosides and broad spectrum antibiotics
PPTX
Aminoglycoside
PPTX
Kanamycin
PPTX
Antibiotic Groups - Aminoglycosides
PPTX
Amioglycoside
PPTX
Neomycin
PPTX
6. aminoglycosides
PPTX
Aminoglycoside and Tetracyclines Antibiotics
PDF
Aminoglycosides (Antibiotics)
PPT
Aminoglycosides
Aminoglycosides antibiotics
30.aminoglycosides
Aminoglycoside ppt
5 aminoglycosides,macrolides, anti tb dental
45 aminoglycosides
Aminoglycosides
Aminoglycoside
Class aminoglycosides 2
Introduction to aminoglycosides and broad spectrum antibiotics
Aminoglycoside
Kanamycin
Antibiotic Groups - Aminoglycosides
Amioglycoside
Neomycin
6. aminoglycosides
Aminoglycoside and Tetracyclines Antibiotics
Aminoglycosides (Antibiotics)
Aminoglycosides
Ad

Viewers also liked (20)

PPT
Aminoglycosides(medicinal chemistry by p.ravisankar)
PPTX
Aminoglycoside
PDF
Class macrolides
PPTX
Macrolides
PPTX
PPTX
Macrolide (l)
PPT
Macrolidos.
PDF
The role of macrolide in the era of antimicrobial resistance - Professor Susa...
PPT
Antibiotics
PPT
Erythromycin
PPTX
Nmr mujtaba
PPT
Antibiotics
PPT
8. macrolides and others
PPTX
Aminoglycosides
PPTX
Azithromycin for prevention of exacerbations of copd
PPT
Pharmacology of aminoglycosides and macrolides
PDF
Pharmacology - Protein Synthesis Inhibitor
PPTX
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
PPTX
Antibiotics chloramphenicol and macrolides
PPTX
Tetracycline and Chloramphenicol
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycoside
Class macrolides
Macrolides
Macrolide (l)
Macrolidos.
The role of macrolide in the era of antimicrobial resistance - Professor Susa...
Antibiotics
Erythromycin
Nmr mujtaba
Antibiotics
8. macrolides and others
Aminoglycosides
Azithromycin for prevention of exacerbations of copd
Pharmacology of aminoglycosides and macrolides
Pharmacology - Protein Synthesis Inhibitor
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
Antibiotics chloramphenicol and macrolides
Tetracycline and Chloramphenicol
Ad

Similar to Muztaba (20)

PPTX
Aminoglycosides 16-April 2024.pptx gc gv
PPT
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
PPTX
Aminoglycoside Antibiotics.pptx
PPT
inhibitor of bacterial Protein synthesis.ppt
PPTX
aminoglycosideppt-160110093602.pptx
PPTX
Aminoglycosides antibiotics
PPT
Aminoglycosides.ppt
PPTX
group 1 pharmaceutical chemistry 91.pptx
PPTX
Aminoglycoside by sumit
PPTX
Drugs that inhibit protein synthesis-aminoglycosides, chloramphenical,.pptx
PPTX
Aminoglycosides Antibiotic's
PPTX
Aminoglycosides Antibiotic
PPT
Aminoglycosides
PPTX
Aminoglycosides
PPTX
Aminoglycosides-Streptomycin and other drugs.pptx
PPTX
protein synthesis inhibitors.pptx
PPTX
Aminiglycosides for medical students and bds
PDF
classaminoglycosides2-150525094713-lva1-app6891.pdf
PPTX
Aminoglycosides
PPTX
Aminoglycosides and streptomycin- pharmaceutical Chemistry
Aminoglycosides 16-April 2024.pptx gc gv
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Aminoglycoside Antibiotics.pptx
inhibitor of bacterial Protein synthesis.ppt
aminoglycosideppt-160110093602.pptx
Aminoglycosides antibiotics
Aminoglycosides.ppt
group 1 pharmaceutical chemistry 91.pptx
Aminoglycoside by sumit
Drugs that inhibit protein synthesis-aminoglycosides, chloramphenical,.pptx
Aminoglycosides Antibiotic's
Aminoglycosides Antibiotic
Aminoglycosides
Aminoglycosides
Aminoglycosides-Streptomycin and other drugs.pptx
protein synthesis inhibitors.pptx
Aminiglycosides for medical students and bds
classaminoglycosides2-150525094713-lva1-app6891.pdf
Aminoglycosides
Aminoglycosides and streptomycin- pharmaceutical Chemistry

More from Mohammad Muztaba (17)

PPTX
Myocardial infractionby mohammad muztaba
PPTX
Ischemic heart disease by mohammad muztaba
PPT
Wound healing lecture
PPT
Chronic inflammation
PPTX
Patho inflammation
PPTX
Mediators of inflammation
PPTX
Intracell accumulation final
PPTX
Homeostasis
PPTX
Pathology
PPTX
Pathogenesis of cell injury
PPTX
Glutamate muztaba
PPTX
Aas mujtaba
PPTX
Hmg muztaba
PPTX
Toxicokinetics
PPTX
PPTX
Alzheimer models
Myocardial infractionby mohammad muztaba
Ischemic heart disease by mohammad muztaba
Wound healing lecture
Chronic inflammation
Patho inflammation
Mediators of inflammation
Intracell accumulation final
Homeostasis
Pathology
Pathogenesis of cell injury
Glutamate muztaba
Aas mujtaba
Hmg muztaba
Toxicokinetics
Alzheimer models

Recently uploaded (20)

PDF
NCCN CANCER TESTICULAR 2024 ...............................
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PDF
11 Antiepileptic Drugs.pdf file for pharmacy
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PDF
Demography and community health for healthcare.pdf
PPT
First Aid Training for construction and other
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PPTX
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
PDF
Seizures and epilepsy (neurological disorder)- AMBOSS.pdf
PPTX
Gout, Systemic Lupus Erythematous, RA, AS.pptx
PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
PPTX
INFLAMMATORY BOWEL DISEASE(U,CERATIVE COLITIS AND CHROHN'S DISEASE)
PPTX
ACUTE PANCREATITIS combined.pptx.pptx in kids
PDF
Biochemistry And Nutrition For Bsc (Nursing).pdf
PDF
periodontaldiseasesandtreatments-200626195738.pdf
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PPSX
Man & Medicine power point presentation for the first year MBBS students
PDF
heliotherapy- types and advantages procedure
NCCN CANCER TESTICULAR 2024 ...............................
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Bronchial Asthma2025 GINA Guideline.pptx
11 Antiepileptic Drugs.pdf file for pharmacy
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
Demography and community health for healthcare.pdf
First Aid Training for construction and other
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
Seizures and epilepsy (neurological disorder)- AMBOSS.pdf
Gout, Systemic Lupus Erythematous, RA, AS.pptx
Cranial nerve palsies (I-XII) - AMBOSS.pdf
INFLAMMATORY BOWEL DISEASE(U,CERATIVE COLITIS AND CHROHN'S DISEASE)
ACUTE PANCREATITIS combined.pptx.pptx in kids
Biochemistry And Nutrition For Bsc (Nursing).pdf
periodontaldiseasesandtreatments-200626195738.pdf
ORGAN SYSTEM DISORDERS Zoology Class Ass
Local Anesthesia Local Anesthesia Local Anesthesia
Man & Medicine power point presentation for the first year MBBS students
heliotherapy- types and advantages procedure

Muztaba

  • 1. PRESENTATION ON: AMINOGLYCOSIDE INTEGRAL UNIVERSITY,LUCKNOW Session: 2016-2017 Presented by: Under the guidence of: Mohd Muztaba Dr .Anuradha Mishra M.Pharm 1st year Pharmacology
  • 2.  These are a group of natural and semisynthetic antibiotics having polybasic amino groups linked glycosidically to two or more aminosugar (strephdine2-deoxy streptamine garosamine) residue.  Unlike penicilline which was a chance discovery aminoglycosides are products of deliberate search for drugs effective against gram-negative bacteria.  All aminoglycosides are produced by soil actinomycetes
  • 3. CLASSIFICATION  Systemic aminoglycosides Streptomycine, Amikacin Gentamicin, Sisomicin Kanamycin  Topical aminoglycosides Neomycin , Framycetin
  • 4.  MECHANISM OF ACTION  The aminoglycosides are bactericidal antibiotic  Transport of the aminoglycosides through bacterial cell wall & cytoplasmic membrane (diffusion-outer coat-Gm –ve via porin channel)  Irreversibly Binding to ribosomes (mostly 30s and 50s,30s &50s interface) resulting in inhibition of protein synthesis.
  • 6. MECHANISM OF RESISTANCE  Production of a transferase enzyme or enzymes inactivates the aminoglycoside by acetylation, or phosphorylation. This is the principal type of resistance encountered clinically  There is impaired entry of aminoglycoside into the cell. This may be genotypic, resulting from mutation or deletion of a proteins involved in transport and maintenance of the electrochemical gradient; or phenotypic, eg, resulting from growth conditions under which the oxygen-dependent transport process described above is not functional  The receptor protein on the 30S ribosomal subunit may be deleted or altered as a result of a mutation.
  • 7.  CONTRAINDICATIONS : hypersensitivity to aminoglycosides or bisulfites  DRUG INTERACTION : • Inactivated by penicillins and cephalosporins when coadministered to pateints with renal insufficiency. • Increased incidence of ototoxicity with loop diuretics. • Increased incidence of nephrotoxicity with other nephrotoxic drugs.  SIDE EFFECTS : nausea,vomiting,urticaria,muscles weakness,rash etc.  ADVERSE EFFECTS: vertigo,myocarditis,thrombocytopenia, leukemia,hepatic necrosis,muscle paralysis, etc.  TOXICITY : ototoxicity,nephrotoxicity
  • 8. STREPTOMYCIN • It is older antibiotics and obtained by Streptomyces griseus, used in past but now used for treatment of TB  M.O.A • Inhibit initiation of translation by binding to 16s rRNA.  MECHANISM OF RESISTANCE • Mutations in (16sRNA) or (ribosomal protein) which produce alterations in the streptomycin binding site Cross resistance: • Partial or unidirectional cross resistance occur.
  • 9. Pharmacokinetics • Neither absorbed nor destroyed in git. • Absorption from injection site in muscle is rapid. • Distributed extracellularly, volume of distribution 0.3 L/kg • It is not metabolized. Excreted unchanged in urine • Plasma half life is 2-4 hrs Adverse effects • Vestibular disturbances, auditory disturbances • Nephrotoxicity • Hypersensitivity are rare-rashes, eosinophilia, dermatitis • Pain at injection site
  • 10. CONTRAINDICATION: pregnancy causes foetal ototoxicity DOSE: Tb – 1g or 0.75 g i.m OD or thrice weekly for 30-60 days Acute infection: 1g i.m OD or BD for 7-10 days USES: TB, given with pencillin/ampicillin/vancomycin for 4-6 weeks • Plague: rapid cure within 7-12 days • Tularemia: Streptomycin cures it in 7-10 days
  • 11. GENTAMYCIN  Gentamicin is an aminoglycoside isolated from Micromonospora purpurea . It is effective against both gram- positive and gram-negative organisms Antimicrobial Activity  Gentamicin sulfate inhibits in vitro many strains of staphylococci and coliforms and other gram-negative bacteria.
  • 12. RESISTANCE  gentamicin in combination with vancomycin or a penicilline produces a potent bactericidal effect, which in part is due to enhanced uptake of drug that occurs with inhibition of cell wall synthesis  Resistance to gentamicin rapidly emerges in staphylococci during monotherapy owing to selection of permeability mutants. Ribosomal resistance is rare. Among gram-negative bacteria, resistance is most commonly due to plasmid-encoded aminoglycoside-modifying enzyme  Gram-negative bacteria that are gentamicin-resistant usually are susceptible to amikacin, which is much more resistant to modifying enzyme activity.
  • 13. AMIKACIN  It is a semisynthetic aminoglycoside  It is effective against several gram negative organism including Escherichia coli Mycobacterium tuberculosis  It is bactericidal effect Amikacin in highly effective against pseudomonas  RESISTANCE  decreased uptake and/or accumulation of the drug in bacteria the bacterial expression of enzymes which modify the antibiotic and thereby inactivate it
  • 14. ADVERSE EFFECT • Vertigo • Ataxia • Ototoxicity • Nephrotoxicity USE • Rt i • Bone and joint infection • Skin and soft tissue infection
  • 15. INTRACTION  Amphoterecin b may leads to increase nephrotoxicity and reduce the clearance of amikacin when use in together  Increse risk of ototoxicity with potent diuretics
  • 16. NEOMYCIN & KANAMYCIN  wide spectrum active against Gm-ve bacilli and some gm+ve cocci and obtained from Streptomyces.fradiae Antimicrobial Activity & Resistance  Drugs of the neomycin group are active against gram-positive and gram-negative bacteria and some mycobacteria.and streptococci are generally resistant. Mechanisms of antibacterial action and resistance are the same as with other aminoglycosides.  The widespread use of these drugs in bowel preparation for elective surgery has resulted in the selection of resistant organisms and some outbreaks of enterocolitis in hospitals. Cross-resistance between kanamycin and neomycin is complete.
  • 17.  USES:Topically used in skin, eye and external ear infections combined with bacitracin or polymyxin-B to widen antibacterial spectrum and to prevent emergence of resistant strains Orally  Preparation of bowel before surgery 1 gm TDS ADVERSE EFFECT  Applied topically neomycin has low sensitizing potential However, rashes do occur.  Oral neomycin has a damaging effect on intestinal villi- prolonged treatment can induce malabsorption syndrome with diarrhoea  It can decrease the absorption of digoxin and many other drugs, as well as bile acids.
  • 18. FARAMYCETIN  it is very similar to neomycin. It is too toxic for systemic administration and is used topically on skin, eye, ear in the same manner as neomycin.